. 2002 Mar;105(3):263–266. doi: 10.1046/j.1365-2567.2002.01379.x

Table 1. Studies demonstrating association between tumour-expressed FasL and apoptosis and loss of TILs in situ in human cancers.

Tumour type	Ref.	Cases studied (n)	FasL's association with apoptosis and loss of TILs
Ovarian	10	132	Decreased CD3⁺ and CD8⁺ TILs
Colon	13	41	Increased apoptosis of TILs (P < 0·01); decreased TIL numbers
Oesophageal	14	106	Decreased CD8⁺ TILs (P = 0·0011); increased apoptosis of TILs″(n = 6, P < 0·05);⁹ decreased TIL numbers (n = 6, P < 0·05)⁹
Mycosis fungoides lymphoma	12	21	Increased apoptosis of CD8⁺ TILs; decreased CD8⁺ TIL numbers (P < 0·02)
Gastric cancer	11	100	Increased apoptosis of TILs (P = 0·057)
Angiosarcoma	15	40	Decreased CD3⁺ and CD8⁺ TILs (P ≤ = 0·004)